Billie Bonevski, Laura Twynman, Fabiana Lorencatto, Susan Michie and Robert West
Presenter(s)
Professor Billie Bonevski Research Fellow, University of Newcastle, Calvary Mater Hospital, Australia
Abstract
Background
Implementation of evidence-based practice is a challenge in all areas of healthcare. Behavioural support for smoking cessation is no exception: while there is limited evidence on this, it suggests that fidelity to treatment manuals where these exist is moderate. Comparing treatment manuals and behavioural support as delivered in practice in terms of BCTs could provide a basis for training practitioners to improve fidelity.
Objectives
This study aims to examine whether using a BCT analysis of what was supposed to be delivered according to treatment manuals and what was actually delivered could form a practical basis for goal setting, monitoring and feedback and to improve fidelity.
Methods
This study is embedded within ‘Call it Quits’, a trial evaluating a smoking cessation intervention delivered to a socially disadvantaged smoker population through an Australian non-government community welfare service. Fidelity of 10 practitioners is being measured by coding the treatment manual in terms of BCTs and comparing this with the BCTs delivered in 5 sessions for each practitioner. Thus, each practitioner has a score of 0-5 for each BCT specified in the manual.
The results for each practitioner are fed back to him or her in an individual, face-to-face session and goals are set for BCT delivery within a 4 week timeframe. Performance is re-assessed at 4 weeks. The intervention is being evaluated by comparing performance in the 50 recorded sessions before and 4 weeks after the intervention.
Conclusion
The results will be available at the conference. This is an innovative study evaluating use of BCT analysis for performance improvement of healthcare professionals.
Source of funding: Billie Bonevski + Laura Twynman: Cancer Institute NSW.
Robert West, Susan Michie, Fabiana Lorencatto: National Centre for Smoking Cessation and Training.
Declaration of interest: Billie Bonevski, Laura Twynman, Susan Michie: None
Fabiana Lorencatto has received travel funds and hospitality from Pfizer, which manufactures Champix.
Robert West has undertaken research and consultancy for companies that develop and manufacture smoking cessation medications. Robert West has a share of a patent in a novel nicotine delivery device.
